FIRAPY Expands Local Engagement in Thailand Through Two Key Vascular Access Events

May 26, 2025

In April and May 2025, FIRAPY, together with our Thailand partner K2 Medical, participated in two important regional events to promote far-infrared therapy’s growing role in vascular access care.


First Step to Vascular Access Care Workshop – Chiang Mai

On April 4, 2025, FIRAPY was featured at the First Step to Vascular Access Care Chiang Mai 2025, hosted by the Department of Surgery, Faculty of Medicine, Chiang Mai University. Held in Chiang Mai, Thailand, the workshop attracted healthcare professionals from across Northern Thailand.

At Booth No. 2, K2 Medical presented FIRAPY’s clinical benefits in improving vascular access function and preventing complications in hemodialysis patients. A key moment during the event was a live demonstration for Professor Dr. Kittipan Rerkasem, M.D., Ph.D., Head of the Vascular Surgery Unit at Maharaj Nakorn Chiang Mai Hospital, which opened further discussions on FIRAPY’s potential applications beyond dialysis.


“Are Your Kidneys OK?” Kidney Health Awareness Event – Bangkok

On May 23, 2025, FIRAPY participated in another important public health event, “Are Your Kidneys OK? Detect Early, Protect Kidney Health”, organized by the Nephrology Society of Thailand in Bangkok. This event focused on early detection and protection of kidney function, attracting a wide range of healthcare providers and public attendees.

At this event, the K2 Medical team once again introduced FIRAPY’s application in supporting long-term vascular access management for dialysis patients. The exhibition drew strong attention from both nephrology professionals and nurses, highlighting FIRAPY’s relevance in daily clinical practice and its potential for broader application in chronic kidney care.

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button

Both events provided valuable opportunities to connect directly with frontline healthcare providers, from surgeons to dialysis nursing teams, reinforcing FIRAPY’s positioning as a non-invasive, guideline-supported solution for vascular access care. We sincerely thank K2 Medical for their continued efforts to expand FIRAPY’s presence and impact in Thailand’s dialysis care community.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts